welcome message

On behalf of organizing committee we are delighted to invite you all to the upcoming conference of  “8th International Conference on Cardiovascular Diseases and Therapeutics” taking place on July 24–25, 2025 in the enchanting city of  Paris, France

CVDT 2025 conference provides a global stage for cardiologists, researchers, healthcare professionals, and industry leaders to come together, exchange insights, explore groundbreaking innovations, and forge collaborations that will shape the future of cardiovascular medicine and therapeutics.

With a carefully curated program featuring keynote sessions, expert panel discussions, and interactive workshops, the conference promises to foster meaningful dialogue and provide valuable insights into the latest trends and challenges in cardiovascular healthcare.

Theme: The Future of Cardiovascular Therapeutics: Challenges and Opportunities

About conference

The “8th International Conference on Cardiovascular Diseases and Therapeutics” will be held on July 24-25, 2025, in the beautiful city of Paris, France. This conference is an important gathering for professionals in the field of cardiovascular health, offering a platform to explore the latest research, innovations, and advancements in the diagnosis, treatment, and prevention of cardiovascular diseases.

Key Features of the Conference:

1. Esteemed Speakers:Leading cardiologists, researchers, and healthcare professionals will present cutting-edge research and share their expertise on the latest advancements in cardiovascular diseases and therapeutics.

2. Scientific Sessions:The conference will feature a comprehensive program of scientific sessions, focusing on various aspects of cardiovascular health, including heart failure, cardiology therapeutics, clinical trials, and emerging treatment methodologies.

3. Interactive Workshops:Hands-on sessions will be offered to enhance practical skills and provide experience with advanced diagnostic tools, cardiovascular devices, and innovative treatment techniques.

4. Exhibitor Showcase:Industry leaders will showcase the latest cardiovascular products, medical devices, and technologies, providing an exclusive opportunity to discover innovations and collaborate with top industry representatives.

5. Networking Opportunities:The conference provides opportunities to connect with global healthcare professionals, researchers, and industry experts. It’s a great platform to exchange ideas, build relationships, and collaborate on advancing cardiovascular care.

6. Continuing Education:Attendees can earn accredited Continuing Medical Education (CME) credits while staying updated on the latest trends, therapeutic approaches, and clinical practices in cardiovascular medicine.

Target audience

The target audience of a CVDT 2025 typically includes a wide range of healthcare professionals, researchers, and industry experts involved in the field of cardiovascular health. These individuals are interested in learning about the latest advancements in the diagnosis, treatment, and prevention of heart and vascular diseases. Here’s a detailed breakdown of the key target audience groups:

1. Cardiologists
2. Healthcare Administrators
3. Cardiovascular Surgeons
4. Cardiovascular Researchers and Scientists
5. Pharmaceutical and Biotech Industry Professionals
6. Healthcare Policy Makers and Public Health Officials
7. Medical Students, Residents, and Fellows
8. Health and Wellness Experts
9. Healthcare Educators and Trainers
10. Cardiac Surgeons
11. Nurses and Nurse Practitioners
12. Healthcare Administrators
13. Cardiovascular Patients and Advocates

Why to attend

Attending the CVDT 2025 Conference can offer numerous benefits for healthcare professionals, researchers, and industry leaders involved in cardiovascular medicine. Here are the key reasons why attending this conference is valuable:

1. Stay Updated on the Latest Research and Innovations

2. Networking Opportunities

3. Educational Opportunities

4. Enhance Clinical Practice

5. Foster Career Development

6. Access to the Latest Clinical Guidelines and Therapeutic Approaches

7. Global Perspective on Cardiovascular Health

8. Get Exposure to Cutting-Edge Technologies and Innovations

9. Contribute to the Future of Cardiovascular Medicine

Participation benefits

The Participation Benefits of attending Dental education 2025 conference offer significant value for attendees.

1. Attend Keynote Presentations: Gain access to world-class researchers and thought leaders in psychiatry and mental health, offering valuable insights into the latest trends and discoveries in the field.

2. Access to All Sessions: Full access to all conference sessions including workshops, symposia, and panel discussions ensures a comprehensive learning experience, covering diverse topics and cutting-edge research.

3. OCM Signed Certificate: A certificate signed by the Organizing Committee Members (OCM) formally acknowledges your participation and contribution to the conference, which can enhance your professional portfolio.

4. Global Recognition: By networking with prominent experts and peers, you can significantly increase your professional visibility and reputation within the global research community.

5. Abstract Publication: Your conference abstracts can be published with a unique DOI in respected international journals, granting your research international exposure and academic credibility.

6. Conference Materials: Receive conference handbooks and kits, containing key materials and resources that support your ongoing learning and professional development.

7. Networking Opportunities: Exclusive networking events provide opportunities to interact with leading figures in the field, fostering connections that could lead to future research collaborations and career opportunities.

Sessions/Tracks

1.Cardiovascular Diseases

Cardiovascular diseases (CVDs) refer to a group of disorders that affect the heart and blood vessels. These diseases disrupt the normal functioning of the cardiovascular system, which is responsible for circulating blood and oxygen throughout the body.

By prioritizing prevention, early diagnosis, and effective treatment, the global burden of CVDs can be significantly reduced, saving lives and improving well-being

2.Cardiovascular therapeutics

Cardiovascular therapeutics refers to the branch of medicine focused on the treatment and management of diseases and conditions affecting the heart and blood vessels. It includes a wide range of strategies, treatments, and interventions designed to improve cardiovascular health and prevent complications such as heart attacks, strokes, and other related disorders.

3. Cardiovascular Genetics and Genomics

Cardiovascular Genetics and Genomics is a field of study that focuses on understanding the genetic factors that contribute to cardiovascular diseases (CVDs) and how genomic technologies can be used to improve diagnosis, treatment, and prevention. It combines insights from genetics, which looks at specific genes and their functions, and genomics, which examines the entire genetic material of an organism.

4. Cardiovascular Regenerative Medicine

Cardiovascular Regenerative Medicine is an emerging field of medicine focused on repairing, replacing, or regenerating damaged heart tissue and blood vessels using advanced biological and technological approaches. It combines principles of regenerative medicine, cell therapy, tissue engineering, and stem cell science to promote healing and restore normal heart function, particularly in cases of cardiovascular diseases (CVD)

5. Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes refer to the various heart and blood vessel-related problems that can arise as a result of diabetes, especially when blood sugar levels are not well controlled over time. Both Type 1 and Type 2 diabetes increase the risk of cardiovascular diseases (CVD), leading to serious complications that affect the heart and vascular system. The long-term high blood sugar levels (hyperglycemia) in diabetes contribute to damage to blood vessels and the heart.By managing diabetes effectively and addressing these risk factors, the likelihood of cardiovascular complications can be significantly reduced.

6. Pediatric Cardiology

Pediatric Cardiology is a specialized field of medicine that focuses on the diagnosis, treatment, and management of heart conditions in children, from infants to adolescents. It deals with both congenital and acquired heart conditions that affect the cardiovascular system in young patients. Pediatric cardiologists work alongside other healthcare professionals to provide care tailored to children’s unique needs, aiming for better long-term outcomes and quality of life.

7. Hypertension and Vascular Health

Hypertension and Vascular Health refers to the relationship between high blood pressure (hypertension) and the health of the blood vessels (vascular system). Hypertension is a condition in which the force of the blood against the walls of the arteries is consistently too high. This increased pressure can damage the blood vessels and organs over time, leading to a range of vascular health issues. Overall, hypertension is a major risk factor for vascular health problems, but with proper management and lifestyle changes, the negative impact on the vascular system can be mitigated, reducing the risk of heart disease and other complications.

8. Hypertension treatment

Hypertension treatment involves managing high blood pressure (hypertension) through a combination of lifestyle changes and medications, with the goal of lowering blood pressure to a healthy range and preventing complications like heart disease, stroke, and kidney damage. Hypertension treatment involves a comprehensive approach, including lifestyle changes and, if necessary, medications. The goal is to lower blood pressure to a healthy level (usually below 130/80 mm Hg) to reduce the risk of complications like heart disease, stroke, and kidney damage.

9. Cardiovascular pharmacology

Cardiovascular Pharmacology is the branch of pharmacology that focuses on the study of drugs and medications used to treat cardiovascular diseases (CVD). It involves understanding how these drugs affect the heart, blood vessels, and overall circulatory system, including their mechanisms of action, therapeutic uses, side effects, and potential interactions. Cardiovascular pharmacology plays a critical role in treating heart and vascular diseases by using drugs that modify cardiovascular function, prevent complications, and improve quality of life.

10. Women’s Cardiovascular Health

Women’s Cardiovascular Health refers to the unique aspects of cardiovascular diseases (CVD) and risk factors in women. While heart disease is often seen as a primarily male health concern, cardiovascular health in women requires special attention due to differences in anatomy, physiology, hormonal influences, and risk factors that affect women differently than men. Women are also more likely to experience different symptoms of heart disease, and their cardiovascular health often faces distinct challenges at various stages of life.

11. Cardiac Toxicity and Oncology

Cardiac Toxicity and Oncology refers to the adverse effects that cancer treatments, particularly chemotherapy and radiation, can have on the heart and cardiovascular system. While cancer therapies are crucial for treating cancer, some of these treatments can cause damage to the heart, leading to cardiotoxicity. This toxicity can manifest as a variety of heart-related complications, ranging from mild effects like high blood pressure to more severe outcomes such as heart failure.

12. Cardiac Nursing

Cardiac Nursing is a specialized field of nursing focused on providing care to individuals with cardiovascular conditions, including heart diseases, disorders of the circulatory system, and post-surgical cardiac recovery. Cardiac nurses are trained to assess, diagnose, and manage heart-related health issues, providing both acute and long-term care for patients with heart conditions. This field involves working closely with cardiologists, other healthcare professionals, and patients to optimize heart health and improve outcomes for those with cardiovascular problems.

13. Cardiovascular failure

Cardiovascular Failure refers to a condition where the heart and blood vessels are unable to function effectively to meet the body’s needs for oxygen and nutrients. It can involve the heart failing to pump blood efficiently (heart failure) or the circulatory system failing to maintain adequate blood flow and pressure, leading to insufficient perfusion of organs and tissues. This can result from various underlying conditions that affect the heart's ability to pump, the vessels' ability to carry blood or both.

14. Heart failure medications      

Heart Failure Medications are a group of drugs prescribed to help manage the symptoms of heart failure, improve the heart’s ability to pump blood, and reduce the risk of complications. These medications can help prevent the progression of the disease, alleviate symptoms like shortness of breath and fluid retention, and improve overall quality of life. The choice of medication depends on the type and severity of heart failure and the individual patient's condition.

15. Arrhythmia treatment

Arrhythmia Treatment refers to the medical management and interventions used to restore a normal heart rhythm or control abnormal rhythms (arrhythmias). An arrhythmia occurs when the electrical impulses in the heart that regulate heartbeats become irregular, too fast (tachycardia), too slow (bradycardia), or erratic. The treatment for arrhythmias depends on the type, severity, symptoms, and underlying causes. Treatment for arrhythmias aims to restore normal heart rhythm, control heart rate, and prevent complications such as stroke or heart failure

16. Coronary Artery Diseases

Coronary Artery Disease (CAD) also known as Coronary Heart Disease (CHD) or Ischemic Heart Disease (IHD) refers to the condition in which the coronary arteries (the blood vessels that supply oxygen-rich blood to the heart muscle) become narrowed or blocked due to the buildup of fatty deposits (atherosclerosis). This reduces the blood flow to the heart, leading to insufficient oxygen supply to the heart muscle, which can cause chest pain (angina), heart attacks, and other serious heart conditions.

17. Cardiac Electrophysiology

Cardiac Electrophysiology is the branch of cardiology that deals with the study and treatment of the electrical activity of the heart. It focuses on understanding how electrical impulses regulate the heart's rhythm and how abnormalities in these impulses can lead to arrhythmias (irregular heartbeats). Cardiac electrophysiology involves diagnosing, managing, and treating disorders related to the heart's electrical system.

18. Cardiomyopathy and Stroke

Cardiomyopathy and stroke are two serious health conditions that can be interconnected in certain circumstances, though they are distinct medical issues with different causes, symptoms, and treatments. Cardiomyopathy refers to diseases of the heart muscle that affect its structure and function. The condition can impair the heart's ability to pump blood effectively, which can lead to heart failure and other complications. A stroke occurs when there is a disruption of blood flow to a part of the brain, leading to brain cell death

19. Cardiomyopathy symptoms

Cardiomyopathy symptoms refer to the signs and experiences that individuals may have when their heart muscle is weakened or damaged. These symptoms are related to the heart's reduced ability to pump blood efficiently, leading to a range of physical effects on the body. These symptoms may vary depending on the type of cardiomyopathy (e.g., dilated, hypertrophic, restrictive, or arrhythmogenic right ventricular cardiomyopathy) and the severity of the condition

20.Cardiomyopathy treatment

Cardiomyopathy treatment aims to manage symptoms, prevent complications, and improve heart function. The specific treatment approach depends on the type of cardiomyopathy, its severity, and any underlying conditions. Treatment for cardiomyopathy focuses on alleviating symptoms, improving heart function, and preventing complications such as arrhythmias or stroke. A combination of medications, lifestyle changes, medical devices, and surgical interventions is used, depending on the type and severity of cardiomyopathy. Early diagnosis and management are crucial to improving quality of life and preventing the progression of the disease.

21. Heart Transplantation

Heart transplantation is a surgical procedure in which a diseased or damaged heart is replaced with a healthy donor heart. It is typically considered a last-resort treatment for patients with severe heart failure or other heart conditions that cannot be managed with medications, lifestyle changes or other medical interventions. Regular follow-up care and lifestyle adjustments are necessary for the patient to maintain the health of the transplanted heart.

22. Biomarkers in Cardiovascular Medicine

Biomarkers in cardiovascular medicine are measurable indicators that can help diagnose, predict, monitor, or evaluate the treatment of cardiovascular diseases (CVD). These biomarkers provide valuable information about the presence and severity of heart-related conditions, as well as the body’s response to treatments. They can be found in blood, urine, or tissues, and are crucial in both clinical practice and research. Biomarkers in cardiovascular medicine play a crucial role in diagnosing, managing, and predicting the progression of heart diseases.

23. Cardiovascular Imaging Advance

Cardiovascular imaging advancements have greatly improved the diagnosis, treatment, and monitoring of cardiovascular diseases (CVDs).These advancements include new techniques, technologies, and tools that offer more detailed, accurate, and non-invasive ways to assess heart health. The goal is to improve early detection, reduce risks, enhance treatment precision, and provide real-time insights into heart function.with improved precision and non-invasive techniques, physicians can detect heart conditions earlier, monitor disease progression more effectively, and make more informed treatment decisions

24. Artificial Intelligence in Cardiology

Artificial Intelligence (AI) in cardiology is revolutionizing the field by enhancing diagnostic accuracy, improving treatment plans, and streamlining workflows. AI algorithms can analyze complex cardiovascular data, such as imaging, electrocardiograms (ECGs), and patient histories, to provide insights that aid in early detection, risk stratification, and personalized care. AI is transforming cardiology by improving diagnostic accuracy, enhancing treatment personalization, and enabling more efficient healthcare delivery

25. Cardiac Rehabilitation and Preventive Cardiology

Cardiac Rehabilitation and Preventive Cardiology are essential components of modern cardiovascular care, focusing on improving heart health, preventing cardiovascular diseases, and helping patients recover after heart-related events or surgeries. Both fields involve comprehensive, multidisciplinary approaches to managing cardiovascular health, with an emphasis on lifestyle modifications, early intervention, and long-term wellness.

26. Nutrition, Diet, and Cardiovascular Health

Nutrition, Diet, and Cardiovascular Health are closely intertwined, as what we eat plays a fundamental role in both the prevention and management of cardiovascular diseases (CVD). An optimal diet can reduce the risk of developing conditions like heart disease, hypertension, stroke and atherosclerosis. Nutrition impacts several key factors, such as cholesterol levels, blood pressure,blood sugar and weight, all of which are essential in maintaining heart health.

27. Novel Drug Therapies for Cardiovascular Conditions

Novel Drug Therapies for Cardiovascular Conditions are crucial in advancing the treatment of cardiovascular diseases (CVD), providing more effective and targeted approaches for patients. The development of new therapies aims to address unmet clinical needs, improve outcomes, and reduce the burden of cardiovascular conditions such as heart failure, coronary artery disease (CAD), arrhythmias, and hypertension.

28. The Future of Cardiovascular Drug Delivery Systems

The future of cardiovascular drug delivery systems is an exciting and rapidly evolving area of medical technology that holds the potential to revolutionize the treatment of cardiovascular diseases (CVD). Advanced drug delivery systems (DDS) are designed to improve the efficacy, safety, and precision of therapies for cardiovascular conditions, such as heart failure, hypertension, arrhythmias, coronary artery disease and cardiovascular inflammation

Associations and societies

American Heart Association (AHA)

European Society of Cardiology (ESC)

American College of Cardiology (ACC)

World Heart Federation (WHF)

British Cardiovascular Society (BCS)

International Society of Hypertension (ISH)

Heart Failure Society of America (HFSA)

Harvard Medical School (HMS)

Stanford University School of Medicine

Johns Hopkins University School of Medicine

Imperial College London (UK)

University of California, San Francisco (UCSF) School of Medicine

University of Oxford (UK)

University of Michigan Medical School